316 related articles for article (PubMed ID: 36150627)
1. New Biology of Pheochromocytoma and Paraganglioma.
Pacak K
Endocr Pract; 2022 Dec; 28(12):1253-1269. PubMed ID: 36150627
[TBL] [Abstract][Full Text] [Related]
2. International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes.
Pacak K; Clifton-Bligh R
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36883571
[TBL] [Abstract][Full Text] [Related]
3. Phaeochromocytoma: a catecholamine and oxidative stress disorder.
Pacak K
Endocr Regul; 2011 Apr; 45(2):65-90. PubMed ID: 21615192
[TBL] [Abstract][Full Text] [Related]
4. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
5. Pheochromocytoma and paraganglioma.
Pacak K; Wimalawansa SJ
Endocr Pract; 2015 Apr; 21(4):406-12. PubMed ID: 25716634
[TBL] [Abstract][Full Text] [Related]
6. Personalized Management of Pheochromocytoma and Paraganglioma.
Nölting S; Bechmann N; Taieb D; Beuschlein F; Fassnacht M; Kroiss M; Eisenhofer G; Grossman A; Pacak K
Endocr Rev; 2022 Mar; 43(2):199-239. PubMed ID: 34147030
[TBL] [Abstract][Full Text] [Related]
7. Familial pheochromocytomas and paragangliomas.
King KS; Pacak K
Mol Cell Endocrinol; 2014 Apr; 386(1-2):92-100. PubMed ID: 23933153
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
Kuo MJM; Nazari MA; Jha A; Pacak K
Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
[TBL] [Abstract][Full Text] [Related]
9. Imaging of Pheochromocytoma and Paraganglioma.
Carrasquillo JA; Chen CC; Jha A; Ling A; Lin FI; Pryma DA; Pacak K
J Nucl Med; 2021 Aug; 62(8):1033-1042. PubMed ID: 34330739
[TBL] [Abstract][Full Text] [Related]
10. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen JL; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH;
JAMA Oncol; 2017 Sep; 3(9):1204-1212. PubMed ID: 28384794
[TBL] [Abstract][Full Text] [Related]
12. [Hypertension, catecholamine hypersecretion and potential for metastasis: recent progress in the pathophysiology and genetics of pheochromocytoma and paraganglioma].
Plouin PF; Amar L; Gimenez-Roqueplo AP
Bull Acad Natl Med; 2015; 199(2-3):313-9. PubMed ID: 27476312
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. [Pediatric pheochromocytoma and paraganglioma: an update].
Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
[TBL] [Abstract][Full Text] [Related]
15. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
Lima JV; Kater CE
Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
[TBL] [Abstract][Full Text] [Related]
16. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
Bertherat J; Gimenez-Roqueplo AP
Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
[TBL] [Abstract][Full Text] [Related]
17. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.
Waguespack SG; Rich T; Grubbs E; Ying AK; Perrier ND; Ayala-Ramirez M; Jimenez C
J Clin Endocrinol Metab; 2010 May; 95(5):2023-37. PubMed ID: 20215394
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma and functional paraganglioma.
Roman S
Curr Opin Oncol; 2004 Jan; 16(1):8-12. PubMed ID: 14685086
[TBL] [Abstract][Full Text] [Related]
19. Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment.
Talvacchio S; Nazari MA; Pacak K
Curr Opin Endocrinol Diabetes Obes; 2022 Jun; 29(3):294-301. PubMed ID: 35621181
[TBL] [Abstract][Full Text] [Related]
20. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.
Timmers HJ; Taieb D; Pacak K
Horm Metab Res; 2012 May; 44(5):367-72. PubMed ID: 22399235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
